Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages

  • 📰 NBCLA
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 59%

News Noticias

España Últimas Noticias,España Titulares

The tracker could be a valuable tool for Americans scrambling to find GLP-1s, such as Novo Nordisk’s weight loss injection Wegovy and diabetes drug…

Telehealth company Ro launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S.

As if! ‘Clueless' star Alicia Silverstone avoids buying retail to limit environmental toll: ‘It needs to be used first' Ro chose to make the tool free for anyone to use because a"basic inventory management system" for GLP-1s does not exist, making it a major contribution to the broader community that relies on those medications, according to Reitano. He added that opening up the tracker to everyone also makes it more likely for both Ro patients and people not enrolled in the company's programs to access GLP-1s.about availability or a shortage of a GLP-1 at a specific pharmacy in their area.

Reitano said Ro has been building the GLP-1 tracker for about two months. The company hasn't been collaborating with the FDA directly, but providing the agency more real-time data can help it keep its shortage list as up to date as possible, he said. Individuals can sign up to receive automated email alerts about when a specific GLP-1 drug becomes available at a nearby pharmacy. The tracker also alerts patients about changes to the supply of a GLP-1 on the FDA's drug shortage database.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 319. in ES
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Eli Lilly's big GLP-1 investment — plus, what we want from 4 portfolio stock earningsThe Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.
Fuente: CNBC - 🏆 12. / 72 Leer más »

How digital health companies are capitalizing on the GLP-1 boomJoining the market for GLP-1s is a massive opportunity, and digital health companies from Ro to WeightWatchers are battling for market share.
Fuente: CNBC - 🏆 12. / 72 Leer más »